Psychedelic medicine continues to move forward, but minority communities are being left behind.
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
There is much research into psychedelic treatment of mental disorders, but psychedelics might be effective in treating autoimmune disorders as well.
Psychedelic-assisted psychotherapy leads the way in 2020’s top psychedelic papers.
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.
Feasibility, safety, and potential efficacy of psilocybin-assisted group therapy was demonstrated in treating demoralization in this marginalized population.
Harnessing the theoretical and technical synergy between Acceptance and Commitment Therapy (ACT) and Psychedelic Assisted Psychotherapy (PcbAP)
The afterglow effect is commonly referenced in psychedelic literature. However, limited attention is being paid to several uncontrolled variables.
New research shows that ketamine reduces self-dislike, loosening the rigid prejudice toward oneself that can constitute depression.
Experiential avoidance is one transdiagnostic process that may be implicated in the therapeutic benefits of psychedelics.